Effects of telmisartan and valsartan on insulin sensitivity in obese diabetic mice

European Journal of Pharmacology

Volumn 698, Issue 1-3, 2013, Pages 505-510

  Ushijima, Kentarou ^a   Takuma, Masashi ^a   Ando, Hitoshi ^a   Ishikawa Kobayashi, Eiko ^a   Nozawa, Masahiko ^a   Maekawa, Tomohiro ^a   Shiga, Tsuyoshi ^b   Fujimura, Akio ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Adiponectin; Angiotensin II type I receptor blocker; Inflammatory cytokine; Peroxisome proliferators activator receptor

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; ADIPOCYTOKINE; ADIPONECTIN; GLUCOSE; INSULIN; INTERLEUKIN 6; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; TELMISARTAN; TUMOR NECROSIS FACTOR ALPHA; VALSARTAN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; AP2 GENE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; FASN GENE; FATTY ACID SYNTHASE GENE; GAPDH GENE; GENE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; INTERLEUKIN 6 GENE; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESE DIABETIC MOUSE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TUMOR NECROSIS FACTOR ALPHA GENE;

ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; BENZIMIDAZOLES; BENZOATES; BODY WEIGHT; DIABETES MELLITUS; EATING; FATTY ACID SYNTHETASE COMPLEX; FATTY ACID-BINDING PROTEINS; GENE EXPRESSION REGULATION; HOMEOSTASIS; INSULIN RESISTANCE; INTERLEUKIN-6; MALE; MICE; MICE, OBESE; PPAR GAMMA; RNA, MESSENGER; TETRAZOLES; TUMOR NECROSIS FACTOR-ALPHA; VALINE;

EID: 84871922155     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.11.022     Document Type: Article

References (38)

1. T. Albrektsen, K.S. Frederiksen, W.E. Holmes, E. Boel, K. Taylor, and J. Fleckner Novel genes regulated by the insulin sensitizer rosiglitazone during adipocyte differentiation Diabetes 51 2002 1042 1051 (Pubitemid 34438348)
2. H. Ando, H. Yanagihara, Y. Hayashi, Y. Obi, S. Tsuruoka, T. Takamura, S. Kaneko, and A. Fujimura Rhythmic messenger ribonucleic acid expression of clock genes and adipocytokines in mouse visceral adipose tissue Endocrinology 146 2005 5631 5636 (Pubitemid 41653080)
3. J.P. Bastard, M. Maachi, C. Lagathu, M.J. Kim, M. Caron, H. Vidal, J. Capeau, and B. Feve Recent advances in the relationship between obesity, inflammation, and insulin resistance Eur. Cytokine. Netw. 17 2006 4 12
4. R.A. Benndorf, T. Rudolph, D. Appel, E. Schwedhelm, R. Maas, F. Schulze, E. Silberhorn, and R.H. Böger Telmisartan improves insulin sensitivity in nondiabetic patients with essential hypertension Metabolism 55 2006 1159 1164 (Pubitemid 44219053)
5. S.C. Benson, H.A. Pershadsingh, C.I. Ho, A. Chittiboyina, P. Desai, M. Pravenec, N. Qi, J. Wang, M.A. Avery, and T.W. Kurtz Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity Hypertension 43 2004 993 1002 (Pubitemid 38579904)
6. A.H. Berg, T.P. Combs, X. Du, M. Brownlee, and P.E. Scherer The adipocyte-secreted protein Acrp30 enhances hepatic insulin action Nat. Med. 7 2001 947 953 (Pubitemid 32756433)
7. J. Berger, and D.E. Moller The mechanisms of action of PPARs Annu. Rev. Med. 53 2002 409 435 (Pubitemid 34177889)
8. A.R. Brasier, A. Recinos 3rd, and M.S. Eledrisi Vascular inflammation and the renin-angiotensin system Arterioscler. Thromb. Vasc. Biol. 22 2002 1257 1266 (Pubitemid 34875734)
9. M. Chandran, S.A. Phillips, T. Ciaraldi, and R.R. Henry Adiponectin: more than just another fat cell hormone? Diabetes Care 26 2003 2442 2450 (Pubitemid 36993340)
10. R. Clasen, M. Schupp, A. Foryst-Ludwig, C. Sprang, M. Clemenz, M. Krikov, C. Thöne-Reineke, T. Unger, and U. Kintscher PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin Hypertension 46 2005 137 143 (Pubitemid 40946504)
11. M. de Gasparo, K.J. Catt, T. Inagami, J.W. Wright, and T. Unger International union of pharmacology. XXIII. The angiotensin II receptors Pharmacol. Rev. 52 2000 415 472
12. D.V. Erbe, K. Gartrell, Y.L. Zhang, V. Suri, S.J. Kirincich, S. Will, M. Perreault, S. Wang, and J.F. Tobin Molecular activation of PPARgamma by angiotensin II type 1-receptor antagonists Vasc. Pharmacol. 45 2006 154 162 (Pubitemid 44716729)
13. European Medicines Agency, 2009. European public assessment report (MicardisPlus), 〈http://www.ema.europa.eu/docs/en-GB/document-library/EPAR- Scientific-Discussion/human/000413/WC500028547.pdf〉 (last update: May 6, 2009)
14. R. Fogari, G. Derosa, A. Zoppi, A. Rinaldi, P. Lazzari, E. Fogari, A. Mugellini, and P. Preti Comparison of the effects of valsartan and felodipine on plasma leptin and insulin sensitivity in hypertensive obese patients Hypertension Res. 28 2005 209 214 (Pubitemid 40812604)
15. D.L. Gerhold, F. Liu, G. Jiang, Z. Li, J. Xu, M. Lu, J.R. Sachs, A. Bagchi, A. Fridman, D.J. Holder, T.W. Doebber, J. Berger, A. Elbrecht, D.E. Moller, and B.B. Zhang Gene expression profile of adipocyte differentiation and its regulation by peroxisome proliferator-activated receptor-gamma agonists Endocrinology 143 2002 2106 2118 (Pubitemid 34521558)
16. G.S. Hotamisligil, N.S. Shargill, and B.M. Spiegelman Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance Science 259 1993 87 91 (Pubitemid 23036092)
17. W.A. Hsueh, and R. Law The central role of fat and effect of peroxisome proliferator-activated receptor-gamma on progression of insulin resistance and cardiovascular disease Am. J. Cardiol. 92 2003 3J 9J
18. Z.H. Israili Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension J. Hum. Hypertens. 14 2000 S73 S86
19. C. Jiang, A.T. Ting, and B. Seed PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines Nature 391 1998 82 86 (Pubitemid 28079219)
20. H. Koike, T. Konse, T. Sada, T. Ikeda, A. Hyogo, D. Hinman, H. Saito, and H. Yanagisawa Olmesartan medoxomil, a novel potent angiotensin II blocker Annu. Rep. Sankyo. Res. Lab. 55 2003 1 91
21. J.M. Lehmann, L.B. Moore, T.A. Smith-Oliver, W.O. Wilkison, T.M. Willson, and S.A. Kliewer An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma) J. Biol. Chem. 270 1995 12953 12956
22. N. Maeda, M. Takahashi, T. Funahashi, S. Kihara, H. Nishizawa, K. Kishida, H. Nagaretani, M. Matsuda, R. Komuro, N. Ouchi, H. Kuriyama, K. Hotta, T. Nakamura, I. Shimomura, and Y. Matsuzawa PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein Diabetes 50 2001 2094 2099 (Pubitemid 33643677)
23. H. Müller-Fielitz, J. Landolt, M. Heidbreder, S. Werth, F.M. Vogt, O. Jöhren, and W. Raasch Improved insulin sensitivity after long-term treatment with AT1 blockers is not associated with PPARγ target gene regulation Endocrinology 153 2012 1103 1115
24. J.M. Nagel, A.B. Tietz, B. Göke, and K.G. Parhofer The effect of telmisartan on glucose and lipid metabolism in nondiabetic, insulin-resistant subjects Metabolism 55 2006 1149 1154 (Pubitemid 44215933)
25. V. Rotter, I. Nagaev, and U. Smith Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects J. Biol. Chem. 278 2003 45777 45784 (Pubitemid 37432722)
26. A.K. Saha, P.R. Avilucea, J.M. Ye, M.M. Assifi, E.W. Kraegen, and N.B. Ruderman Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo Biochem. Biophys. Res. Commun. 314 2004 580 585 (Pubitemid 38084758)
27. M. Schupp, J. Janke, R. Clasen, T. Unger, and U. Kintscher Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity Circulation 109 2004 2054 2057 (Pubitemid 38620211)
28. J.J. Senn, P.J. Klover, I.A. Nowak, and R.A. Mooney Interleukin-6 induces cellular insulin resistance in hepatocytes Diabetes 51 2002 3391 3399 (Pubitemid 35403441)
29. T. Shiuchi, M. Iwai, H.S. Li, L. Wu, L.J. Min, J.M. Li, M. Okumura, T.X. Cui, and M. Horiuchi Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice Hypertension 43 2004 1003 1010 (Pubitemid 38579905)
30. H. Takagi, and T. Umemoto Telmisartan increases adiponectin levels: a meta-analysis and meta-regression of randomized head-to-head trials Int. J. Cardiol. 155 2012 448 451
31. H. Takagi, and T. Umemoto Telmisartan improves insulin sensitivity: a meta-analysis of randomized head-to-head trials Int. J. Cardiol. 156 2012 92 96
32. P. Tontonoz, and B.M. Spiegelman Fat and beyond: the diverse biology of PPARgamma Annu. Rev. Biochem. 77 2008 289 312
33. C. Top, B.Y. Cingözbay, H. Terekeci, Y. Küçü kardali, M.E. Onde, and M. Danaci The effects of valsartan on insulin sensitivity in patients with primary hypertension J. Int. Med. Res. 30 2002 15 20 (Pubitemid 34618717)
34. P. Trayhurn, and I.S. Wood Adipokines: inflammation and the pleiotropic role of white adipose tissue Br. J. Nutr. 92 2004 347 355 (Pubitemid 40277057)
35. U.S. Food and Drug Administration, 2005. Drug Approval Package (Telmisartan; Application No.: 20-850) 〈http://www.accessdata.fda.gov/ drugsatfda-docs/nda/98/20850-Micardis.cfm〉 (last update: July 5, 2005)
36. J.M. Ye, N. Dzamko, A.J. Hoy, M.A. Iglesias, B. Kemp, and E. Kraegen Rosiglitazone treatment enhances acute AMP-activated protein kinase-mediated muscle and adipose tissue glucose uptake in high-fat-fed rats Diabetes 55 2006 2797 2804 (Pubitemid 44923679)
37. F. Younis, N. Stern, R. Limor, Y. Oron, S. Zangen, and T. Rosenthal Telmisartan ameliorates hyperglycemia and metabolic profile in nonobese Cohen-Rosenthal diabetic hypertensive rats via peroxisome proliferator activator receptor-gamma activation Metabolism 59 2010 1200 1209
38. F. Ziemke, and C.S. Mantzoros Adiponectin in insulin resistance: lessons from translational research Am. J. Clin. Nutr. 91 2010 258S 261S